pubmed-article:3411740 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:3411740 | lifeskim:mentions | umls-concept:C0019345 | lld:lifeskim |
pubmed-article:3411740 | lifeskim:mentions | umls-concept:C0001367 | lld:lifeskim |
pubmed-article:3411740 | lifeskim:mentions | umls-concept:C1292733 | lld:lifeskim |
pubmed-article:3411740 | pubmed:issue | 11 | lld:pubmed |
pubmed-article:3411740 | pubmed:dateCreated | 1988-10-4 | lld:pubmed |
pubmed-article:3411740 | pubmed:abstractText | To determine the effectiveness of an antiviral to prevent herpes labialis during a brief, high-risk circumstance, 147 persons with a history of sun-induced recurrences were treated prophylactically with oral acyclovir or matching placebo and were observed during their ski holidays. Five (7%) of 75 acyclovir-treated subjects developed lesions compared with 19 (26%) of 72 persons in the placebo group. | lld:pubmed |
pubmed-article:3411740 | pubmed:language | eng | lld:pubmed |
pubmed-article:3411740 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3411740 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:3411740 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3411740 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3411740 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:3411740 | pubmed:month | Sep | lld:pubmed |
pubmed-article:3411740 | pubmed:issn | 0098-7484 | lld:pubmed |
pubmed-article:3411740 | pubmed:author | pubmed-author:MillsJJ | lld:pubmed |
pubmed-article:3411740 | pubmed:author | pubmed-author:DavisL GLG | lld:pubmed |
pubmed-article:3411740 | pubmed:author | pubmed-author:SpruanceS LSL | lld:pubmed |
pubmed-article:3411740 | pubmed:author | pubmed-author:HamillM LML | lld:pubmed |
pubmed-article:3411740 | pubmed:author | pubmed-author:HogeW SWS | lld:pubmed |
pubmed-article:3411740 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:3411740 | pubmed:day | 16 | lld:pubmed |
pubmed-article:3411740 | pubmed:volume | 260 | lld:pubmed |
pubmed-article:3411740 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:3411740 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:3411740 | pubmed:pagination | 1597-9 | lld:pubmed |
pubmed-article:3411740 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:3411740 | pubmed:meshHeading | pubmed-meshheading:3411740-... | lld:pubmed |
pubmed-article:3411740 | pubmed:meshHeading | pubmed-meshheading:3411740-... | lld:pubmed |
pubmed-article:3411740 | pubmed:meshHeading | pubmed-meshheading:3411740-... | lld:pubmed |
pubmed-article:3411740 | pubmed:meshHeading | pubmed-meshheading:3411740-... | lld:pubmed |
pubmed-article:3411740 | pubmed:meshHeading | pubmed-meshheading:3411740-... | lld:pubmed |
pubmed-article:3411740 | pubmed:meshHeading | pubmed-meshheading:3411740-... | lld:pubmed |
pubmed-article:3411740 | pubmed:meshHeading | pubmed-meshheading:3411740-... | lld:pubmed |
pubmed-article:3411740 | pubmed:meshHeading | pubmed-meshheading:3411740-... | lld:pubmed |
pubmed-article:3411740 | pubmed:meshHeading | pubmed-meshheading:3411740-... | lld:pubmed |
pubmed-article:3411740 | pubmed:meshHeading | pubmed-meshheading:3411740-... | lld:pubmed |
pubmed-article:3411740 | pubmed:meshHeading | pubmed-meshheading:3411740-... | lld:pubmed |
pubmed-article:3411740 | pubmed:meshHeading | pubmed-meshheading:3411740-... | lld:pubmed |
pubmed-article:3411740 | pubmed:meshHeading | pubmed-meshheading:3411740-... | lld:pubmed |
pubmed-article:3411740 | pubmed:meshHeading | pubmed-meshheading:3411740-... | lld:pubmed |
pubmed-article:3411740 | pubmed:meshHeading | pubmed-meshheading:3411740-... | lld:pubmed |
pubmed-article:3411740 | pubmed:meshHeading | pubmed-meshheading:3411740-... | lld:pubmed |
pubmed-article:3411740 | pubmed:year | 1988 | lld:pubmed |
pubmed-article:3411740 | pubmed:articleTitle | Acyclovir prevents reactivation of herpes simplex labialis in skiers. | lld:pubmed |
pubmed-article:3411740 | pubmed:affiliation | Department of Medicine, University of Utah School of Medicine, Salt Lake City 84132. | lld:pubmed |
pubmed-article:3411740 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:3411740 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:3411740 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
pubmed-article:3411740 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3411740 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3411740 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3411740 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3411740 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3411740 | lld:pubmed |